Post-genomic health advances and its implications in developing countries.

Abstract

This chapter reviews the potential of the human genome project, comparative genomics, functional genomics and proteomics in studying the molecular aspects of human health and diseases in Developing Countries. The uses of DNA technology in the molecular diagnosis of infectious and noncommunicable diseases, of gene targeting in gene therapy for genetic and non-genetic disorders, and of pharmacogenomics in developing new drugs are discussed. Some challenges to biotechnology research and development, and the role of international organizations and multinational companies are described.